Abstract
Since the first reported clinical application of robot-assisted minimally invasive esophagectomy (RAMIE) in the early 2000s, RAE has gained increasing popularity worldwide in the recent 20 years. Although RAE is not yet regarded as standard surgical treatment for esophageal cancer, a lot of institutions have reported the safety and feasibility of robotic system in both transhiatal esophagectomy (THE) and transthoracic esophagectomy (TTE). Most of the studies focused on the surgical outcomes and recent oncologic results, the RAMIE have shown with short blood loss and effective early oncologic outcomes: R0 resection rate approximately 95% and rare locoregional recurrence. This may show that RAMIE has a tendency of improved long-term survival for esophageal cancer. Thus, the objective of this study is to report the early oncological control results of robot assisted esophagectomy, based on the previous publications and our initial experience. Key words: Esophageal cancer; Robot-assisted minimally invasive esophagectomy; Oncological outcome
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
